Who owns PYXIS ONCOLOGY INC?
- Ticker: PYXS
- CUSIP Number: 747324101
Tip: Access positions for across all investors
Analyze quarterly positions in Pyxis Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pyxis Oncology stock
Who bought or sold PYXIS ONCOLOGY INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Pfizer | 7.0M | $9.2M | 0% | Mar 2026 |
|
| Laurion Capital Management | 5.0M | $7.3M | 4% | Mar 2026 |
|
| Vanguard Capital Management | 2.0M | $3.0M | 100% | Mar 2026 |
|
| Palo Alto Investors | 1.0M | $1.5M | -3% | Mar 2026 |
|
| 683 Capital Management | 896k | $1.3M | 0% | Mar 2026 |
|
| Renaissance Technologies | 889k | $1.3M | 22% | Mar 2026 |
|
| BlackRock | 789k | $1.2M | 1% | Mar 2026 |
|
| Geode Capital Management | 598k | $874k | 4% | Mar 2026 |
|
| Longaeva Partners | 503k | $735k | 100% | Mar 2026 |
|
| Jacobs Levy Equity Management | 461k | $673k | 100% | Mar 2026 |
|
| Millennium Management | 398k | $581k | -46% | Mar 2026 |
|
| Marshall Wace | 354k | $517k | -9% | Mar 2026 |
|
| Jane Street | 330k | $482k | -58% | Mar 2026 |
|
| Decheng Capital | 327k | $477k | 0% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 301k | $439k | 100% | Mar 2026 |
|
| UBS Group | 254k | $371k | -35% | Mar 2026 |
|
| State Street Corporation | 249k | $363k | 3% | Mar 2026 |
|
| XTX Topco | 200k | $292k | -31% | Mar 2026 |
|
| HealthInvest Partners AB | 197k | $1.6M | -68% | Mar 2026 |
|
| Acadian Asset Management | 144k | $209k | 100% | Mar 2026 |
|
| Bank of New York Mellon | 134k | $196k | -19% | Mar 2026 |
|
| Citadel Advisors | 128k | $187k | -66% | Mar 2026 |
|
| NewEdge Wealth | 116k | $169k | 0% | Mar 2026 |
|
| Northern Trust | 102k | $149k | 0% | Mar 2026 |
|
| Susquehanna International | 84k | $122k | -71% | Mar 2026 |
|
| Bridgeway Capital Management | 81k | $119k | 12% | Mar 2026 |
|
| Two Sigma Investments | 73k | $107k | -31% | Mar 2026 |
|
| Morgan Stanley | 70k | $102k | -22% | Mar 2026 |
|
| PanAgora Asset Management | 69k | $101k | 100% | Mar 2026 |
|
| Cable Car Capital | 62k | $90k | 0% | Mar 2026 |
|
| Stifel Financial | 51k | $74k | 100% | Mar 2026 |
|
| Toronto-Dominion Bank | 50k | $73k | 100% | Mar 2026 |
|
| Barclays | 50k | $73k | -17% | Mar 2026 |
|
| University Of Chicago | 49k | $71k | 0% | Mar 2026 |
|
| Goldman Sachs Group | 47k | $69k | -46% | Mar 2026 |
|
| J. Derek Lewis & Associates | 43k | $63k | -19% | Mar 2026 |
|
| Commonwealth Equity Services | 35k | $51k | -13% | Mar 2026 |
|
| LPL Financial | 34k | $49k | -4% | Mar 2026 |
|
| Point72 Asset Management | 32k | $47k | -83% | Mar 2026 |
|
| Cetera Investment Advisers | 27k | $40k | 0% | Mar 2026 |
|
| Dimensional Fund Advisors | 26k | $38k | -48% | Mar 2026 |
|
| Graham Capital Management | 23k | $33k | -88% | Mar 2026 |
|
| Maia Wealth | 21k | $31k | -3% | Mar 2026 |
|
| Vanguard Global Advisers | 21k | $31k | 100% | Mar 2026 |
|
| Catalyst Funds Management Pty | 20k | $30k | 100% | Mar 2026 |
|
| Squarepoint Ops | 18k | $26k | 100% | Mar 2026 |
|
| Bank of America Corporation | 17k | $25k | 100% | Mar 2026 |
|
| Advisor Group Holdings | 14k | $20k | -20% | Mar 2026 |
|
| Two Sigma Securities | 14k | $20k | 100% | Mar 2026 |
|
| FMR | 12k | $17k | -7% | Mar 2026 |
|
| Paces Ferry Wealth Advisors | 11k | $17k | 0% | Mar 2026 |
|
| Qube Research & Technologies | 11k | $17k | -92% | Mar 2026 |
|
| China Universal Asset Management | 11k | $16k | 9% | Mar 2026 |
|
| Tower Research Capital | 10k | $15k | -4% | Mar 2026 |
|
| Goss Wealth Management | 10k | $15k | 0% | Mar 2026 |
|
| Pnc Financial Services | 6.5k | $9.5k | 100% | Mar 2026 |
|
| Winthrop Capital Management | 6.0k | $9.0k | 0% | Mar 2026 |
|
| Royal Bank of Canada | 5.8k | $9.0k | 100% | Mar 2026 |
|
| Hager Investment Management Services | 5.0k | $7.3k | 100% | Mar 2026 |
|
| Mirae Asset Global Investments | 3.2k | $4.7k | 7% | Mar 2026 |
|
| Federated Investors | 3.2k | $4.6k | 68% | Mar 2026 |
|
| Citigroup | 1.7k | $2.5k | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 1.7k | $2.4k | -93% | Mar 2026 |
|
| Gf Fund Management | 1.3k | $1.9k | 3% | Mar 2026 |
|
| NISA Investment Advisors | 961.00 | $1.4k | 0% | Mar 2026 |
|
| UMA Financial Services | 943.00 | $1.4k | 0% | Mar 2026 |
|
| Balyasny Asset Management | 743.00 | $1.1k | -91% | Mar 2026 |
|
| Jones Financial Companies, L.L | 500.00 | $655.000000 | 0% | Mar 2026 |
|
| Wells Fargo & Company | 285.00 | $415.986000 | -88% | Mar 2026 |
|
| Simplex Trading | 253.00 | $369.000500 | -97% | Mar 2026 |
|
| Cornerstone Financial Management | 172.00 | $250.999600 | 100% | Mar 2026 |
|
| CWM | 34.00 | $50.000400 | -51% | Mar 2026 |
|
| Golden State Equity Partners | 10.00 | $14.000000 | 100% | Mar 2026 |
|
| Caitong International Asset Management | 4.00 | $6.000000 | 100% | Mar 2026 |
|
| SBI Securities | 1.00 | $1.000000 | 0% | Mar 2026 |
|
| SRS Capital Advisors | 1.00 | $20.000000 | -93% | Mar 2026 |
|
Who sold out of Pyxis Oncology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| ExodusPoint Capital Management | Dec 2025 | 318k | $365k |
| Quadrature Capital | Dec 2025 | 101k | $116k |
| OMERS Administration Corporation | Dec 2025 | 67k | $77k |
| Velan Capital Investment Management | Dec 2025 | 40k | $46k |
| Hrt Financial | Dec 2025 | 40k | $45k |
| American Century Companies | Dec 2025 | 32k | $37k |
| Lighthouse Investment Partners | Dec 2025 | 29k | $33k |
| Engineers Gate Manager | Dec 2025 | 23k | $26k |
| Two Sigma Advisers | Dec 2025 | 23k | $26k |
| Fox Run Management | Dec 2025 | 23k | $26k |
| Leucadia National Corporation | Dec 2025 | 16k | $18k |
| Northwestern Mutual Wealth Management Company | Dec 2025 | 12.00 | $14.000400 |